Aclidinium bromide
| CAS No. | 320345-99-1 | Cat. No. | BCP05982 |
| Name | Aclidinium bromide | ||
| Synonyms | LAS 34273; LAS-W-330;LAS34273; LAS W-330;LAS-34273; LAS-W 330; | ||
| Formula | C26H30NO4S2.Br | M. Wt | 564.55 |
| Description | Aclidinium bromide is a long-acting anticholinergic bronchodilator approved by the FDA in 2012 for use in the management of chronic obstructive pulmonary disease (COPD). Aclidinium bromide is an inhalation powder promoted by Forest Pharmaceuticals in the US under the trade name Tudorza Pressair. It is also manufactured and marketed by Menarini Pharmaceuticals in the EU under the trade name Bretaris Genuair, in the UK as Eklira Genuair and in the Canada as Tudorza Genuair | ||
| Pathways | Neuro Signaling Pathway GPCR/G Protein | ||
| Targets | mAChR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.